<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35455394</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Print">1424-8247</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>15</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceuticals (Basel, Switzerland)</Title>
          <ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Natural Phaeosphaeride A Derivatives Overcome Drug Resistance of Tumor Cells and Modulate Signaling Pathways.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">395</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ph15040395</ELocationID>
        <Abstract>
          <AbstractText>In the present study, natural phaeosphaeride A (PPA) derivatives are synthesized. Anti-tumor studies are carried out on the PC3, K562, HCT-116, THP-1, MCF-7, A549, NCI-H929, Jurkat, and RPMI8226 tumor cell lines, and on the human embryonic kidney (HEK293) cell line. All the compounds synthesized turned out to have better efficacy than PPA towards the tumor cell lines listed. Among them, three compounds exhibited an ability to overcome the drug resistance of tumor cells associated with the overexpression of the P-glycoprotein by modulating the work of this transporter. Luminex xMAP technology was used to assess the effect of five synthesized compounds on the activation of intracellular kinase cascades in A431 cells. MILLIPLEX MAP Multi-Pathway Magnetic Bead 9-Plex was used, which allowed for the simultaneous detection of the following nine phosphorylated protein markers of the main intracellular signaling pathways: a universal transcription factor that controls the expression of immune-response genes, apoptosis and cell cycle NFκB (pS536); cAMP-dependent transcription factor (CREB (pS133); mitogen-activated kinase p38 (pT180/pY182); stress-activated protein kinase JNK (pT183/pY185); ribosomal SK; transcription factors STAT3 (pS727) and STAT5A/B (pY694/699); protein kinase B (Akt) (pS473); and kinase regulated by extracellular signals ERK1/2 (pT185/pY187). The effect of various concentrations of PPA derivatives on the cell culture was studied using xCelligence RTCA equipment. The compounds were found to modulate JNK, ERK1/2, and p38 signaling pathways. The set of activated kinase cascades suggests that oxidative stress is the main probable mechanism of the toxic action of PPA derivatives.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abzianidze</LastName>
            <ForeName>Victoria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical Biological Agency, p/o Kuz'molovsky, 188663 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moiseeva</LastName>
            <ForeName>Natalia</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0001-6697-7154</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory of Tumor Cell Genetics, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suponina</LastName>
            <ForeName>Diana</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical Biological Agency, p/o Kuz'molovsky, 188663 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zakharenkova</LastName>
            <ForeName>Sofya</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical Biological Agency, p/o Kuz'molovsky, 188663 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rogovskaya</LastName>
            <ForeName>Nadezhda</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical Biological Agency, p/o Kuz'molovsky, 188663 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laletina</LastName>
            <ForeName>Lidia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Tumor Cell Genetics, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holder</LastName>
            <ForeName>Alvin A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chemistry and Biochemistry, Old Dominion University, 4501 Elkhorn Avenue, Norfolk, VA 23529, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krivorotov</LastName>
            <ForeName>Denis</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical Biological Agency, p/o Kuz'molovsky, 188663 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bogachenkov</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-0797-3457</Identifier>
            <AffiliationInfo>
              <Affiliation>Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical Biological Agency, p/o Kuz'molovsky, 188663 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garabadzhiu</LastName>
            <ForeName>Alexander</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Saint Petersburg State Technological Institute (Technical University), 190013 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ukolov</LastName>
            <ForeName>Anton</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-2911-1260</Identifier>
            <AffiliationInfo>
              <Affiliation>Research Institute of Hygiene, Occupational Pathology and Human Ecology, Federal Medical Biological Agency, p/o Kuz'molovsky, 188663 Saint Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kosorukov</LastName>
            <ForeName>Vyacheslav</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Transgenic Drugs, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 115478 Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharmaceuticals (Basel)</MedlineTA>
        <NlmUniqueID>101238453</NlmUniqueID>
        <ISSNLinking>1424-8247</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ERK 1/2</Keyword>
        <Keyword MajorTopicYN="N">JNK</Keyword>
        <Keyword MajorTopicYN="N">P-glycoprotein</Keyword>
        <Keyword MajorTopicYN="N">anti-tumor activity</Keyword>
        <Keyword MajorTopicYN="N">multidrug resistance</Keyword>
        <Keyword MajorTopicYN="N">natural phaeosphaeride A</Keyword>
        <Keyword MajorTopicYN="N">oxidative stress</Keyword>
        <Keyword MajorTopicYN="N">signaling pathways</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>1</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35455394</ArticleId>
        <ArticleId IdType="pmc">PMC9030166</ArticleId>
        <ArticleId IdType="doi">10.3390/ph15040395</ArticleId>
        <ArticleId IdType="pii">ph15040395</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Stavrovskaya A.A., Stromskaya T.P. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry. 2008;73:592–604. doi: 10.1134/S0006297908050118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1134/S0006297908050118</ArticleId>
            <ArticleId IdType="pubmed">18605983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dewanjee S., Dua T.K., Bhattacharjee N., Das A., Gangopadhyay M., Khanra R., Joardar S., Riaz M., Feo V., Zia-Ul-Haq M. Natural products as alternative choices for P-glycoprotein (P-gp) inhibition. Molecules. 2017;22:871.  doi: 10.3390/molecules22060871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules22060871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008;38:802–832. doi: 10.1080/00498250701867889.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00498250701867889</ArticleId>
            <ArticleId IdType="pubmed">18668431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robey R.W., Pluchino K.M., Hall M.D., Fojo A.T., Bates S.E., Gottesman M.M. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat. Rev. Cancer. 2018;18:452–464. doi: 10.1038/s41568-018-0005-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41568-018-0005-8</ArticleId>
            <ArticleId IdType="pmc">PMC6622180</ArticleId>
            <ArticleId IdType="pubmed">29643473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chevillard S., Vielh P., Vallidire P., Robert J., Marie J.P. A study of the expression of MDR1 gene in solid tumors. Initial results of a multicenter evaluation. Bull. Cancer. 1996;83:626–633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8869042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adamska A., Falasca M. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? World J. Gastroenterol. 2018;24:3222–3238. doi: 10.3748/wjg.v24.i29.3222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v24.i29.3222</ArticleId>
            <ArticleId IdType="pmc">PMC6079284</ArticleId>
            <ArticleId IdType="pubmed">30090003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Binkhathlan Z., Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: Current status and future perspectives. Curr. Cancer Drug Targets. 2013;13:326–346. doi: 10.2174/15680096113139990076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/15680096113139990076</ArticleId>
            <ArticleId IdType="pubmed">23369096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X., Pan G.  Advances in Experimental Medicine and Biology. Volume 1141 Springer; Singapore: 2019. Drug Transporters in Drug Disposition, Effects and Toxicity.</Citation>
        </Reference>
        <Reference>
          <Citation>Gonçalves B.M.F., Cardoso D.S.P., Ferreira U.M.-J. Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. Molecules. 2020;25:3364.  doi: 10.3390/molecules25153364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25153364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi K., Kobayashi Y., Nakamura M., Tamura O., Kogen H. Establishment of Relative and Absolute Configurations of Phaeosphaeride A: Total Synthesis of ent-Phaeosphaeride A. J Org. Chem. 2015;2015:1243–1248. doi: 10.1021/jo5025046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jo5025046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abzianidze V., Poluektova E., Bolshakova K., Panikorovskii T., Bogachenkov A., Berestetskiy A. Crystal structure of natural phaeosphaeride A. Acta Crystallogr. 2015;E71:o625–o626. doi: 10.1107/S205698901501395X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1107/S205698901501395X</ArticleId>
            <ArticleId IdType="pmc">PMC4571431</ArticleId>
            <ArticleId IdType="pubmed">26396831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wake M.S., Watson C.J. STAT3 the oncogene—Still eluding therapy? FEBS J. 2015;282:2600–2611. doi: 10.1111/febs.13285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.13285</ArticleId>
            <ArticleId IdType="pubmed">25825152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnston P.A., Grandis J.R. STAT3 signaling: Anticancer strategies and challenges. Mol. Interv. 2011;11:18–26. doi: 10.1124/mi.11.1.4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/mi.11.1.4</ArticleId>
            <ArticleId IdType="pmc">PMC3063716</ArticleId>
            <ArticleId IdType="pubmed">21441118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maloney K.N., Hao W., Xu J., Gibbons J., Hucul J., Roll D., Brady S.F., Schroeder F.C., Clardy J. Phaeosphaeride A, an inhibitor of STAT3-dependent signaling isolated from an endophytic fungus. Org. Lett. 2006;8:4067–4070. doi: 10.1021/ol061556f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ol061556f</ArticleId>
            <ArticleId IdType="pmc">PMC2518690</ArticleId>
            <ArticleId IdType="pubmed">16928075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao H., Cheng H.Y., Cook R.G., Tweardy D.J. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res. 2003;63:3923–3930.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12873986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatzimpaloglou A., Yavropoulou M.P., Rooij K.E., Biedermann R., Mueller U., Kaskel S., Sarli V. Total Synthesis and Biological Activity of the Proposed Structure of Phaeosphaeride A. J. Org. Chem. 2012;77:9659–9667. doi: 10.1021/jo301662e.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jo301662e</ArticleId>
            <ArticleId IdType="pubmed">23050677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatzimpaloglou A., Kolosov M., Eckols T.K., Tweardy D.J., Sarli V. Synthetic and Biological Studies of Phaeosphaerides. J. Org. Chem. 2014;79:4043–4054. doi: 10.1021/jo500545d.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jo500545d</ArticleId>
            <ArticleId IdType="pubmed">24735379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abzianidze V., Prokofieva D., Chisty L., Bolshakova K., Berestetskiy A., Panikorovskii T., Bogachenkov A., Holder A. Synthesis of natural phaeosphaeride A derivatives and an in vitro evaluation of their anti-cancer potential. Bioorg. Med. Chem. Lett. 2015;25:5566–5569. doi: 10.1016/j.bmcl.2015.10.048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmcl.2015.10.048</ArticleId>
            <ArticleId IdType="pubmed">26508550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abzianidze V., Beltyukov P., Zakharenkova S., Moiseeva N., Mejia J., Holder A., Trishin Y., Berestetskiy A., Kuznetsov V. Synthesis and Biological Evaluation of Phaeosphaeride A Derivatives as Antitumor Agents. Molecules. 2018;23:3043.  doi: 10.3390/molecules23113043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules23113043</ArticleId>
            <ArticleId IdType="pmc">PMC6278656</ArticleId>
            <ArticleId IdType="pubmed">30469343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abzianidze V., Zakharenkova S., Moiseeva N., Beltyukov P., Polukeev V., Dubrovskii Y., Kuznetsov V., Trishin Y., Mejia J., Holder A. Towards lead compounds as anti-cancer agents via new phaeosphaeride A derivatives. Bioorg. Med. Chem. Lett. 2019;29:59–61. doi: 10.1016/j.bmcl.2018.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmcl.2018.11.003</ArticleId>
            <ArticleId IdType="pubmed">30447888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zakharenkova S., Abzianidze V., Moiseeva N., Lukina D., Chistyi L., Krivorotov D., Trishin Y. Antitumor activity of phaeosphaeride A modified with nitrogen heterocyclic groups. Mendeleev Commun. 2021;31:662–663. doi: 10.1016/j.mencom.2021.09.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mencom.2021.09.023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barbosa R., Acevedo L.A., Marmorstein R. The MEK/ERK Network as a Therapeutic Target in Human Cancer. Mol. Cancer Res. 2021;19:361–374. doi: 10.1158/1541-7786.MCR-20-0687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-20-0687</ArticleId>
            <ArticleId IdType="pmc">PMC7925338</ArticleId>
            <ArticleId IdType="pubmed">33139506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yip H.Y.K., Papa A. Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells. 2021;10:659.  doi: 10.3390/cells10030659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells10030659</ArticleId>
            <ArticleId IdType="pmc">PMC8002322</ArticleId>
            <ArticleId IdType="pubmed">33809714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panda M., Biswal B.K. Cell signaling and cancer: A mechanistic insight into drug resistance. Mol. Biol. Rep. 2019;46:5645–5659. doi: 10.1007/s11033-019-04958-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11033-019-04958-6</ArticleId>
            <ArticleId IdType="pubmed">31280421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senga S.S., Grose R.P. Hallmarks of cancer—The new testament. Open Biol. 2021;11:200358. doi: 10.1098/rsob.200358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1098/rsob.200358</ArticleId>
            <ArticleId IdType="pmc">PMC7881179</ArticleId>
            <ArticleId IdType="pubmed">33465324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D’yakonov V.A., Makarov A.A., Dzhemileva L.U., Ramazanov I.R., Makarova E.K., Dzhemilev U.M. Natural trienoic acids as anticancer agents: First stereoselective synthesis, cell cycle analysis, induction of apoptosis, cell signaling and mitochondrial targeting studies. Cancers. 2021;13:1808.  doi: 10.3390/cancers13081808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers13081808</ArticleId>
            <ArticleId IdType="pmc">PMC8070279</ArticleId>
            <ArticleId IdType="pubmed">33920067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filimonova K.S., Rogovskaya N.Y., Beltyukov P.P., Babakov V.N. Assessing hepatoprotective effects of antioxidants on amiodarone-induced cytotoxicity in human hepatoma HepaRG cell line. Med. Extrem. Situat. 2021;3:43–51. doi: 10.47183/mes.2021.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.47183/mes.2021.030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gamboa A.C., Gronchi A., Cardona K. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine. CA Cancer J. Clin. 2020;70:200–229. doi: 10.3322/caac.21605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3322/caac.21605</ArticleId>
            <ArticleId IdType="pubmed">32275330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galland F., Seady M., Taday J., Smaili S.S., Gonçalves C.A., Leite M.C. Astrocyte culture models: Molecular and function characterization of primary culture, immortalized astrocytes and C6 glioma cells. Neurochem. Int. 2019;131:104538. doi: 10.1016/j.neuint.2019.104538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuint.2019.104538</ArticleId>
            <ArticleId IdType="pubmed">31430518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turkson J., Bowman T., Adnane J., Zhang Y., Djeu J.Y., Sekharam M., Frank D., Holzman L., Wu J., Sebti S., et al.  Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol. Cell. Biol. 1999;19:7519–7528. doi: 10.1128/MCB.19.11.7519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.19.11.7519</ArticleId>
            <ArticleId IdType="pmc">PMC84756</ArticleId>
            <ArticleId IdType="pubmed">10523640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ki Y., Parka J., Lee J., Shin I., Koh H. JNK and p38 MAPK regulate oxidative stress and the inflammatory response in chlorpyrifos-induced apoptosis. Toxicol. Lett. 2013;218:235–245. doi: 10.1016/j.toxlet.2013.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.toxlet.2013.02.003</ArticleId>
            <ArticleId IdType="pubmed">23416140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y., Wang Q., Evers B.M., Chung D.H. Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis. Pediatr. Res. 2005;58:1192–1197. doi: 10.1203/01.pdr.0000185133.65966.4e.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1203/01.pdr.0000185133.65966.4e</ArticleId>
            <ArticleId IdType="pmc">PMC2653865</ArticleId>
            <ArticleId IdType="pubmed">16306192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corre I., Paris F., Huot J. The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells. Oncotarget. 2017;8:55684. doi: 10.18632/oncotarget.18264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.18264</ArticleId>
            <ArticleId IdType="pmc">PMC5589692</ArticleId>
            <ArticleId IdType="pubmed">28903453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saint-Ruf C., Nardeux P., Estrade S., Brouty-Boye D., Lavialle C., Rhim J.S., Cassingena R. Accelerated malignant conversion of human HBL-100 cells by the v-Ki-ras oncogene. Exp. Cell Res. 1988;176:60–67. doi: 10.1016/0014-4827(88)90120-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-4827(88)90120-6</ArticleId>
            <ArticleId IdType="pubmed">2836229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moiseeva N.I., Laletina L.A., Fetisov T.I., Makhmudova L.F., Manikaylo A.E., Fomina L.Y., Burov D.A., Lesovaya E.A., Bokhyan B.Y., Zinovieva V.Y., et al.  Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells. Int. J. Mol. Sci. 2022;23:3183.  doi: 10.3390/ijms23063183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms23063183</ArticleId>
            <ArticleId IdType="pmc">PMC8951302</ArticleId>
            <ArticleId IdType="pubmed">35328603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mechetner E.B., Roninson I.B. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. USA. 1992;89:5824–5828. doi: 10.1073/pnas.89.13.5824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.89.13.5824</ArticleId>
            <ArticleId IdType="pmc">PMC402110</ArticleId>
            <ArticleId IdType="pubmed">1352877</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
